1-(3-(Benzo[d][1,3]dioxol-5-yl)propyl)-4-phenylpiperazine hydrochloride

ID: ALA2153421

Chembl Id: CHEMBL2153421

PubChem CID: 53329620

Max Phase: Preclinical

Molecular Formula: C20H25ClN2O2

Molecular Weight: 324.42

Molecule Type: Small molecule

Names and Identifiers

Synonyms: LASSBio-632 | LASSBio-632|CHEMBL2153421

Canonical SMILES:  Cl.c1ccc(N2CCN(CCCc3ccc4c(c3)OCO4)CC2)cc1

Standard InChI:  InChI=1S/C20H24N2O2.ClH/c1-2-6-18(7-3-1)22-13-11-21(12-14-22)10-4-5-17-8-9-19-20(15-17)24-16-23-19;/h1-3,6-9,15H,4-5,10-14,16H2;1H

Standard InChI Key:  SNQHMUTXHNMYRL-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 324.42

Molecular Weight (Monoisotopic): 324.1838

AlogP: 3.17

#Rotatable Bonds: 5

Polar Surface Area: 24.94

Molecular Species: NEUTRAL

HBA: 4

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.47

CX LogP: 4.01

CX LogD: 2.91

Aromatic Rings: 2

Heavy Atoms: 24

QED Weighted: 0.84

Np Likeness Score: -0.96

References

1. Romeiro LA, da Silva Ferreira M, da Silva LL, Castro HC, Miranda AL, Silva CL, Noël F, Nascimento JB, Araújo CV, Tibiriçá E, Barreiro EJ, Fraga CA..  (2011)  Discovery of LASSBio-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties.,  46  (7): [PMID:21549456] [10.1016/j.ejmech.2011.04.032]

Source

Source(1):

• Scientific Literature